Calfee, Halter & Griswold LLP
Human coagulation factor light chain protein and use of the same
In the invention, the minimum inhibitory concentrations of human coagulation factor light-chain proteins against different Gram-negative bacteria are detected with the in vitro antibacterial activity and the inhibiting effect of the human coagulation factor light-chain proteins against different Gram-negative bacteria is detected with the in vivo antibacterial activity. It has been shown that human coagulation factor light-chain proteins have an obvious inhibitory effect on the Gram-negative bacteria, so as to develop a novel class of medicaments for treating Gram-negative bacteria infection. It has been demonstrated by mass spectrometry and silver staining that human coagulation factor light-chain proteins have the effect on hydrolyzing and eliminating the endotoxin, which facilitates the development of a novel class of medicaments for treating endotoxemia. The human coagulation factor light-chain proteins are light chain proteins of human coagulation factors VII, IX, and X, as well as a protein having homology of more than 50% thereof.
Chengdu Sourcebio Limited-Liability Company
C C Y A A C A C A A A
C07K C12Y Y02A A61P A61P C12Y A61P C12Y A61P A61K A61K
inventional additional additional inventional inventional additional inventional additional inventional additional inventional
Ling Xu Dengjiao Dongsheng Jinwu
Li Song Ma Liao Chen